Xi‐Qi Xu

577 total citations
24 papers, 362 citations indexed

About

Xi‐Qi Xu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xi‐Qi Xu has authored 24 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Xi‐Qi Xu's work include Pulmonary Hypertension Research and Treatments (12 papers), Vascular Anomalies and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Xi‐Qi Xu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Vascular Anomalies and Treatments (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Xi‐Qi Xu collaborates with scholars based in China, United Kingdom and United States. Xi‐Qi Xu's co-authors include Zhi‐Cheng Jing, Yan Wu, Yuejin Yang, Zhi-Yan Han, Bo Xu, Shengshou Hu, Rutai Hui, Zengwu Wang, Hao Wang and Xin Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Xi‐Qi Xu

19 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi‐Qi Xu China 9 310 178 86 48 32 24 362
Zhi-Yan Han China 7 250 0.8× 148 0.8× 71 0.8× 38 0.8× 26 0.8× 10 297
Felix Gerhardt Germany 12 296 1.0× 231 1.3× 39 0.5× 40 0.8× 20 0.6× 28 416
Fu-Hua Peng China 10 251 0.8× 141 0.8× 34 0.4× 63 1.3× 35 1.1× 27 351
Prieya Wason United States 3 379 1.2× 264 1.5× 84 1.0× 20 0.4× 27 0.8× 7 402
Abby Poms United States 7 585 1.9× 374 2.1× 100 1.2× 52 1.1× 54 1.7× 12 610
Roela Sadushi‐Kolici Austria 14 512 1.7× 409 2.3× 129 1.5× 29 0.6× 46 1.4× 28 606
Gregory Elliott United States 7 288 0.9× 115 0.6× 60 0.7× 33 0.7× 21 0.7× 10 324
Satenik Harutyunova Germany 13 398 1.3× 236 1.3× 45 0.5× 38 0.8× 26 0.8× 33 442
Aaron W. Trammell United States 8 360 1.2× 202 1.1× 31 0.4× 76 1.6× 32 1.0× 21 417
Fumiaki Kato Japan 12 242 0.8× 103 0.6× 34 0.4× 56 1.2× 24 0.8× 34 330

Countries citing papers authored by Xi‐Qi Xu

Since Specialization
Citations

This map shows the geographic impact of Xi‐Qi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi‐Qi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi‐Qi Xu more than expected).

Fields of papers citing papers by Xi‐Qi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi‐Qi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi‐Qi Xu. The network helps show where Xi‐Qi Xu may publish in the future.

Co-authorship network of co-authors of Xi‐Qi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xi‐Qi Xu. A scholar is included among the top collaborators of Xi‐Qi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi‐Qi Xu. Xi‐Qi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Liu, Chao, Dan Lü, Xinxin Yan, et al.. (2024). Association between coronary artery stenosis and myocardial injury in patients with acute pulmonary embolism: A case-control study. Chinese Medical Journal. 137(16). 1965–1972.
5.
Zhang, Zejian, Hui‐Fang Wang, Tian‐Yu Lian, et al.. (2023). Human Plasma IgG N -Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension. Hypertension. 80(9). 1929–1939. 9 indexed citations
6.
Zhu, Yongjian, Yu‐Ping Zhou, Chun‐Yan Cheng, et al.. (2023). Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis‐associated pulmonary hypertension: A single‐arm meta‐analysis. Catheterization and Cardiovascular Interventions. 102(3). 558–567. 1 indexed citations
7.
Liu, Ziyi, Pei‐Wen Wang, Jia Wang, et al.. (2023). Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis. Research and Practice in Thrombosis and Haemostasis. 7(6). 102157–102157. 5 indexed citations
8.
Liu, Qianqian, Lan Wang, Yongjian Zhu, et al.. (2023). Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: A national prospective cohort study. Chinese Medical Journal. 137(6). 669–675.
9.
Li, Fajiu, Ziyang Zhu, Zhuang Tian, et al.. (2022). Non-Ischemic, Non-Hypoxic Myocardial Injury, and Long-Term Mortality in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study. SHILAP Revista de lepidopterología. 2(2). 77–82. 1 indexed citations
10.
Zhou, Yu‐Ping, Yunpeng Wei, Xi‐Qi Xu, et al.. (2022). Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. Journal of the American College of Cardiology. 79(15). 1477–1488. 10 indexed citations
11.
Zhou, Bin, Yongjian Zhu, Yingjie Qi, et al.. (2021). Radiofrequency Catheter Ablation of Supraventricular Tachycardia in Patients With Pulmonary Hypertension: Feasibility and Long-Term Outcome. Frontiers in Physiology. 12. 674909–674909. 8 indexed citations
12.
He, Yangyang, Yi Yan, Jiwang Chen, et al.. (2021). Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease. Acta Pharmacologica Sinica. 43(7). 1710–1720. 17 indexed citations
13.
He, Yangyang, Yi Yan, Xin Jiang, et al.. (2020). Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension. European Respiratory Journal. 56(5). 2000522–2000522. 47 indexed citations
14.
Yue, Yunlong, Yong Liu, Jin Qian, et al.. (2018). IgG4-related disease of pulmonary artery causing pulmonary hypertension. Medicine. 97(20). e10698–e10698. 11 indexed citations
15.
Wu, Danchen, Rui Zhang, Xin Zhang, et al.. (2014). SURVIVAL OF PATIENTS WITH REPAIRED CHD-PAH IN THE MODERN MANAGEMENT ERA. Journal of the American College of Cardiology. 63(12). A1484–A1484. 1 indexed citations
16.
Xu, Xi‐Qi, Xin Jiang, Rui Zhang, et al.. (2014). [Comparison of clinical characteristics and survival on patients with idiopathic pulmonary arterial hypertension and familial pulmonary arterial hypertension during conventional therapy era and targeted therapy era].. PubMed. 42(6). 465–8. 2 indexed citations
17.
Jing, Zhi‐Cheng, Xi‐Qi Xu, David B. Badesch, et al.. (2009). Pulmonary function testing in patients with pulmonary arterial hypertension. Respiratory Medicine. 103(8). 1136–1142. 57 indexed citations
18.
Xu, Xi‐Qi, Zhi‐Cheng Jing, Jinhu Zhang, et al.. (2009). The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Hypertension Research. 32(10). 911–915. 13 indexed citations
19.
Jiang, Xin, Zhi-Yan Han, Xi‐Qi Xu, et al.. (2008). Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension. Chinese Medical Journal. 121(24). 2497–2503. 6 indexed citations
20.
Jing, Zhi‐Cheng, Xi‐Qi Xu, Zhi-Yan Han, et al.. (2007). Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension. CHEST Journal. 132(2). 373–379. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi-Yan Han Breakdown of academic impact, for papers by Felix Gerhardt Breakdown of academic impact, for papers by Fu-Hua Peng Breakdown of academic impact, for papers by Prieya Wason Breakdown of academic impact, for papers by Abby Poms Breakdown of academic impact, for papers by Roela Sadushi‐Kolici Breakdown of academic impact, for papers by Gregory Elliott Breakdown of academic impact, for papers by Satenik Harutyunova Breakdown of academic impact, for papers by Aaron W. Trammell Breakdown of academic impact, for papers by Fumiaki Kato
Rankless by CCL
2026